Viatris Stock Price

0.36 (3.23%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 9,901,125
Bid Price 11.42
Ask Price 11.48
News -
Day High 11.53


52 Week Range


Day Low 11.16
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Viatris Inc VTRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.36 3.23% 11.50 19:49:29
Open Price Low Price High Price Close Price Prev Close
11.16 11.16 11.53 11.47 11.14
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
43,242 9,901,125 $ 11.41 $ 113,006,431 - 9.66 - 16.29
Last Trade Time Type Quantity Stock Price Currency
19:57:32 30 $ 11.44 USD


Draw Mode:

Viatris Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 13.94B 1.21B 1.08B $ 17.89B $ 168.13M -1.05 79.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.33 4.33% 05/23/22 43.60k 0.30%

more financials information »

Viatris News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VTRS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.3811.5310.1410.7215,603,0841.1210.79%
1 Month10.7211.539.7610.4613,984,4980.787.28%
3 Months14.5614.7359.6610.7415,723,572-3.06-21.02%
6 Months13.8915.609.6612.0212,735,547-2.39-17.21%
1 Year15.9816.299.6612.8810,045,870-4.48-28.04%
3 Years16.4618.869.6614.0510,817,080-4.96-30.13%
5 Years16.4618.869.6614.0510,817,080-4.96-30.13%

Viatris Description

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.